Why Dietary Supplements Are the First Pathway for Cannabis Medicine
The cannabis industry has spent years waiting for this moment. As federal rescheduling moves forward, so do the opportunities to develop cannabinoid-based […]
The cannabis industry has spent years waiting for this moment. As federal rescheduling moves forward, so do the opportunities to develop cannabinoid-based […]
Yesterday, the Pennsylvania Senate rejected SB 49, Sen. Dan Laughlin’s Cannabis Control Board bill, on a 27-23 floor vote. Then, within the […]
Cannabis cultivation is, at its core, a controlled environment business, and air quality remains one of the most consistently underestimated variables in […]
As federal policymakers move toward restricting hemp-derived cannabinoid products, a new state-level effort in Colorado is taking the opposite approach by moving […]
At the recent Business of Cannabis event in New York, Robert Sciarrone, Chief Revenue Officer at Curaleaf, shared an MSO’s insider view […]
California’s medical cannabis market began in 1996 when voters passed Proposition 215 (the Compassionate Use Act), making it the first state to […]
The Most Exciting US Market No cannabis market in the United States has experienced a more compelling growth trajectory over the past […]
A Cleveland-based health-tech company, EM2P2, has launched a platform that could change how Americans pay for medical cannabis. Its new product, CannaLnx, […]
As the cannabis industry continues to mature, labeling will continue to shape the way for product identification and consumer safety. Looking ahead […]
Below are excerpts from the conversation at the White House press conference where President Trump signed an Executive Order to move marijuana […]